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Summary Good clinical practice is dependent on continuous audit. Most audits of head and neck cancer treatment planning have been
subjective, with only 5-year survival rates being considered objectively. Improvements in clinical care require not only measurable goals that
relate to patients' perspectives, but also a means of assessing to what extent those goals have been met. In this context, 5-year survival rates
are too crude to be useful, although they remain important for other reasons. Because a simple clinical objective measure of outcome
applicable to head and neck cancer is not available, multiattribute assessment techniques were used to develop a clinically based scale for
outcomes following treatment for head and neck cancer, with domains centred on social function, pain, physical appearance, eating and
speech problems, nausea, donor site problems and shoulder function. Domains were weighted relative to each other; pain (mean weight 85)
and social function (89) were considered most important followed by physical appearance (76), eating (76) and speech problems (74)
A series of graded statements was constructed within each domain and scaled relative to each other. These components were also combined
into an overall scale that will enable objective outcome assessment in this important area of medical care.
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Four-fifths of mouth cancers are squamous cell carcinomas. The
clinical presentations ofvarious head and neck tumours have been
well documented and the International Classification of Diseases
(World Health Organization, 1978) provides a coding classifica-
tion for malignant neoplasms arising within the oral cavity and
adjacent structures. There are two main modalities of head and
neck treatment, radiotherapy and surgery, used singularly or in
conjunction with each other.
Over the years, a range of multidimensional quality of life
(QOL) instruments have been developed to assess patients' phys-
ical, psychological and social functioning in head and neck cancer.
These measures vary in their level of application. There are non-
specific instruments designed for use across a wide range of
chronic disease populations, such as the Sickness Impact Profile
(Bergner et al, 1981), the Nottingham Health Profile (Hunt et al,
1981) and the Karnofsky Index Scale (Karnofsky et al, 1948), and
there are specific measures designed for more homogeneous
patient populations. The Head and Neck Questionnaire (UW
QAL) describes important daily living dysfunction or limitations
that patients complain of as part of head and neck cancer effects
(Sammay et al, 1993); and the European Organization for
Research and Treatment of Cancer Core Quality of Life
Questionnaire for Head and Neck patients (EORTC QOL-
H&N37) includes 37 items concerning disease and treatment-
related symptoms, social function and sexuality (Bjordal et al,
1994). However, despite the importance of assessing outcome of
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treatment, a simple clinically relevant scale has not been devel-
oped, partly because the best and worst health states at the extrem-
ities of such a scale are not obvious. An overall measure ofhealth
outcome in this context must include social, economic, physical
and psychological aspects of health (Selby et al, 1984). Although
well-validated scales exist to assess psychological health in isola-
tion (Telfer and Shepherd, 1993), assessment of the physical and
functional outcomes of treatment, together with the social effects
of these, has traditionally been highly subjective. It has been
shown that patients find it difficult to combine such multidimen-
sional problems into a single measure. However multiattribute
assessment techniques exist (Carter, 1992; Kent, 1992) which
facilitate this process. Much has been written on the use of such
measures for breast cancer, gastrointestinal and testicular cancer,
but little on head and neck cancer, and nothing in relation to intra-
oral cancer (Stalpers, 1989).
Components that should be included may be classified into four
main areas:
(1) Physical and occupational function, for example energy and
ability to carry out expected normal activity.
(2) Somatic problems, for example pain, nausea, vomiting and
other symptoms that result from illness or treatment.
(3) Psychological state.
(4) Effect on social interaction and ability to make contact with
others.
Ifa scale is to be useful then it should grade outcomes with both
accuracy and reliability. Assessment ofpsychological function and
social function is difficult but multiattribute techniques can facili-
tate the incorporation of such subjective values into a clinically
useful scale (Schipper et al, 1984).
There is a discrepancy between patients' and clinicians' percep-
tions of outcomes in the management of oral cancer. Patients'
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objectives for treatment may be unrealistic and differ from their
perceptions ofactual treatment outcome, even when, in a technical
sense, treatment is successful. It has been stated in other contexts
that the definition of success differs widely between patients and
their doctors. In treatment planning, the clinician should seek to
assess the patients' needs and desires and develop a strategy that
will meet their needs rather than formulate stereotyped treatment
plans. This process is difficult however, and where objective
measures ofoutcome health are not available it may be impossible.
Apractical scale should be quick and easy to complete. It is also
important that the scale demonstrates validity and consistency
between measurements. A scale should be sufficiently sensitive to
distinguish degrees of dysfunction, especially as this is a major
criticism ofthe use of5-year survival rates.
An accepted method ofquantifying preference is developing and
attaching utility values to each possible outcome following a clin-
ical decision (Vertinsky and Wong, 1975). Utility in its strictest
sense has been based on a scale with extremes of total health and
death. Utilities inrelation to headand neckcancer are not, however,
easily quantified using this approach. Traditionally, utility assess-
ment techniques also require that respondents integrate all compo-
nents of health into a single value. There is evidence that people
have difficulty in doing this (Schipper et al, 1984).
It has become increasingly apparent that the factors that influ-
ence patients' perceptions are not only medical but also social,
economic and cultural (so-called 'domains' in utility parlance).
While traditional utility assessment methods, such as standard
gamble and time trade-offs, attempt to assess medical utility, they
fail to integrate these other factors (Keeney and Raiffa, 1976).
Multiattribute assessment (MAU) methods, on the other hand,
explicitly allow considerations of non-medical domains and have
therefore been adopted forthe currentproject. These methods have
been well validated by Boyle and Torrance (1984).
The current study therefore develops a composite outcome
utility measure for head and neck cancer treatment using multiat-
tribute techniques investigated by expert clinicians. It also facili-
tates the production of a new scale, designed for clinical use and
based on a sound statistical framework.
MATERIALS AND METHODS
The scale was developed and tested in three phases:
were used to determine the critical contributing factors of health
following treatment for head and neck cancer. This process was
carried out by a delphi panel to ensure that the domains did not
reflect the analyst's own opinion. This panel consisted of a head
and neck oncologist, four maxillofacial surgeons who regularly
treat head and neck tumours, a head and neck oncology/counsellor
and a researcher familiar with decision-making techniques. The
delphi panel considered the interview transcripts and each member
first produced a list of factors that he or she felt were important
contributions to the outcome health state without reference to other
members. These were then discussed with the group, who reached
consensus on a list of factors. The individual factors were further
consolidated by the group to yield eight final domains, each repre-
senting a significant component of health. A series of statements
were derived foreach domain, which described a range ofoutcome
states from the best possible to the worst possible outcome
('intradomain statements') - for example, a domain centred on pain
included statements of 'no pain' and 'pain requiring regular anal-
gesia with opiates.'
Phase 2
After the domains and intradomain statements had been derived,
ten head and neck surgeons were asked to weight the eight
domains relative to one another using a standardized visual
analogue scale (interdomain weights). Anchor points for the scale
ranged from 'unimportant' to 'extremely important' (Figure 1).
The same respondents were then asked to assign scores to each
of the intradomain statements within each domain using the
'feeling thermometer' method as described by Boyle and Torrance
(1984). The statements were weighted relative to one another on a
visual analogue scale (Figure 1), thus allowing a numerical value
to be assigned to each statement ('intradomain scores'). Both
intradomain scores and interdomain weights by this group were
subjected to statistical analysis to produce mean values, standard
deviations and minimum and maximum values.
Phase 3
The inter- and intradomain weightings derived in phase 2 were
used to construct a utility scale for outcomes of head and neck
cancer treatment by application ofthe following equation:
U= 2(W.S.) P x 100 Phase 1 TotalX
Patients who had undergone treatment for head and neck cancer
(35) and consultant and maxillofacial surgeons (5) were inter-
viewed by atrained research worker to identify critical contributing
factors of overall health status . The interviews were unstructured
and included enquiry about physical, functional and social dimen-
sions ofhealth. Following this, interview transcripts were made and
interview abstraction techniques as described by Babbie (1992)
where j = each domain in turn; W. = interdomain weighting for
domain; S. = score for a particular outcome in relation to domain;
U = multiattribute utility; and Total = maximum possible sum of
W. S. (value = 54502).
This resulted in a multiattribute utility score varying between
zero and 100, with zerorepresenting the worstpossible health state
and 100 the best possible health state.
Please mark a cross on the line to indicate how important each factor is to you in your treatment planning of patients with oral carcinoma.
Social function,
Unimportant x d Extremely important
(89 mm)
Figure 1 Visual analogue scale
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Table 1 Domains and interdomain weighting scores
Range
Domains Mean Standard deviation Minimum Maximum
1. Social function 89 6 82 98
2. Pain 85 13 64 98
3. Physical appearance 77 27 5 100
4. Eating problems (swallowing) 76 16 47 95
5. Speech problems 74 19 44 100
6. Nausea 69 17 43 95
7. Donor-site problems 46 17 18 67
8. Shoulder function (stiffness/drop) 46 24 13 86
Scores are shown to the nearest integer.
RESULTS
Domains identified as being important during phase 1 are
described in Table 1 together with mean interdomain weightings,
range and standard deviations for each, based on the respondents'
weightings (phase 2). Each domain represents an important compo-
nent of overall health status following treatment for head and neck
cancer. The domains of pain (mean weight 85) and social function
(89) were considered to be the most important aspects of health,
closely followed by physical appearance (77), eating problems (76)
and speech problems (74) by the expert respondents in this study.
The individual intradomain statements derivedby the delphi panel
foreach domain are shown in Appendix 2, while the mean scores (on
a 100-point scale) and standard deviation data are shown in Table 2
(derived in phase 2). These data together with those presented in
Table 1 can be used to produce an overall utility scale for any
outcome using eqn (i). A worked example is shown in Appendix 1.
DISCUSSION
Approximately 7.6 (Office of Population Censuses and Surveys,
1992) new cases of head and neck cancer per annum per 100 000
ofUK population are detected, and the majority ofthese (60%) are
within the oral cavity. Despite the importance of this disease, no
objective measures of outcome have been developed to date and,
indeed, treatments have been assessed in subjective terms by an ad
hoc combination of the surgeon's perceived value of the outcome
and his or her perception of the patient's opinion of the outcome.
The research described here has developed a scale for an objective
assessment of outcome ofhead and neck cancer management, has
rated the relative importance ofthe components ofthis assessment
and has structured them in such a way that they can be used in a
questionnaire format. The scale presented here will be useful in
many contexts, including audit studies, to evaluate the relative
merit of varying treatment modalities, to examine to what extent
actual treatment outcome is related to patients' perceptions of the
value of outcome and to indicate to patients preoperatively the
likely outcome ofaproposed treatment plan. Itwill be important to
validate this scale further. This should include comparison with
existing scales (caution should be exercised, however, as they are
all eithertoo non-specific ormeasure different aspects ofoutcome)
and also with patient-professional assessments of outcome for a
series ofcases. Further work is in progress to achieve this.
The scale developed here was rated using the opinions of oral
and maxillofacial surgeons trained in the treatment of head and
neckcancer. Clearly, the opinion ofsuchprofessionals is important
in the overall process ofvaluing outcomes of treatment. However,
further studies are needed to investigate the values that patients
may place on outcomes in this area. Such research wouldhighlight
important differences between the perceptions of clinicians and
their patients.
Interestingly, in relation to the perceived relative importance of
the components ofhealth following treatment, surgeons agreed on
the importance of social function but there was a wide range of
weight values for other components. This suggests that this group
of skilled clinicians attached differing importance to the various
components of outcome and, therefore, that it is possible that this
affects their treatment decisions. This lack of consensus deserves
further research. Nevertheless, this new scale is useful in
comparing the outcomes ofthis critical clinical activity.
Table 2 Oral oncology outcome scale
Intradomain Social Pain Physical Eating Speech Nausea Donor site Shoulder
statement function appearance problems problems problems function
Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
score score score score score score score score
1 (Best) 97 3 94 6 98 3 97 3 98 3 97 3 98 3 98 3
2 56 24 78 10 89 5 59 19 85 8 67 21 79 9 76 13
3 34 13 57 17 52 17 32 12 5 19 41 16 63 12 56 16
4 14 6 37 16 28 11 15 10 3 14 21 8 28 13 33 12
5 (Worst) 5 5 13 10 9 5 14 28 6 6 6 5 10 9 11 11
Scores are shown to the nearest integer. See Appendix 2 for details of the specific statements relating the outcome levels (1 = best, 5 = worst) for each domain.
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APPENDIX I A WORDED EXAMPLE OF
PRACTICAL APPLICATION
A patient has undergone surgical treatment for head and neck
cancer. She has slight facial deformity that is noticeable to the clin-
ician only and her shoulder function is normal. She suffers from
intermittent nausea once or twice a week, which is not managed
with medication. Following the procedure, there was some wound
breakdown at the donor site. She suffers occasional pain but this
can be relieved with mild analgesics such as paracetamol. She has
been able to return to work 1 month after surgery, has no speech
difficulties and is able to eat normally. She has the following
scores in each domain.
Domain Description fitting patient Intradomain scores
(from Table 2)
Shoulder function No problems 98
Speech problems Speech normal to trained ear 98
Social function Able to work 97
Eating problems Able to eat a normal diet 97
Physical appearance Slight deformity noticeable to
clinician only 89
Donor site problems Partial graft/wound breakdown 79
Pain Pain requiring intermittent mild
analgesics 78
Nausea Nausea once or twice a week 67
The overall utility (U) for this patient would then be:
U = (intradomain score for physical appearance x interdomain weight for physical appearance) + etc
maximum score (54502) using eqn (i)
U = (89 x 77) + (79 x46) + (67 x 69) + (78 x 85) + (98 x 46) + (97 x 89) +(98 x74) +(97 x 76)
54502
x 100
U = 6853 + 3634 + 4623 + 6630 + 4508 + 8633 + 7252 + 7372
54502
x 100
U= 49505
54502
x 100
U= 90.8
Therefore, on a scale ofzero (worst possible health) to 100 (best possible health), this patient would have an overall utility of 90.8.
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APPENDIX 2 INTRADOMAIN STATEMENTS FOR
EACH DOMAIN
1. Social function
1. Life back to normal (working)
2. Social life limited to friends and family
3. Socializes with family
4. Rarely goes out
5. Housebound.
2. Pain
1. No pain
2. Pain requiring intermittent mild analgesics (paracetamol)
3. Pain requiring regular analgesics (paracetamol or non-steroidal)
4. Pain requiring regular non-steroidal or intermittent synthetic
opiates
5. Pain requiring regular opiates.
3. Physical appearance
1. No visible deformity
2. Slight deformity noticeable to the clinician only
3. Deformity noticeable to the family and friends
4. Obvious facial deformity
5. Severe facial deformity.
4. Eating problems (swallowing)
1. Patient able to eat normal diet
2. Patient able to eat soft foods
3. Patient on liquidized diet
4. Patient on fluids only
5. No diet by mouth ifpossible (enteral feeding required).
5. Speech problems
1. Speech normal to trained ear
2. Speech problems to trained ear only (sh sounds, etc.)
3. Speech defects to untrained ear
4. Patient has to repeat some words
5. Speech mainly unintelligible.
6. Nausea
1. No nausea
2. Nausea once or twice a week
3. Nausea every day, requires antiemetic on a regular basis
4. Nausea for which second line antiemetics are required
(ondansetron)
5. Nausea not controlled with oral medication, continuous infu-
sion required.
7. Donor site problems
1. No problems
2. Partial graft/wound breakdown
3. Pain limitation offunction, up to 4 weeks' treatment needed
for healing
4. Residual deformity with limitation offunction
5. Patient has long-term donor site dysfunction/symptoms.
8. Shoulder function (stiffness/drop)
1. No problems
2. Pain on full rotator cuffmovement
3. Pain on normal movement
4. Limited movement because ofpain
5. No movement without pain.
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